ArticleJornal brasileiro de nefrologia
Translation, cross-cultural adaptation, and validation of the Integrated Palliative Care Outcome Scale Renal (IPOS-Renal) for Brazilian Portuguese.
Article in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic Kidney Disease (CKD) is associated with a high symptom burden. In Brazil, there is no specific instrument to assess symptoms in CKD patients receiving palliative care. The Integrated Palliative Care Outcome Scale Renal (IPOS-Renal) has been translated and validated in 13 languages.
objectiveTo translate, cross-culturally adapt, and validate the IPOS-renal for Brazilian Portuguese.
methodsA methodological study conducted in eight phases: conceptual definition, forward translation, back-translation, expert review, cognitive interviews, proofreading, psychometric testing, and final reporting. A total of 153 stage 5 CKD patients were assessed with the IPOS-renal and the Edmonton Symptom Assessment System (ESAS-r) between February and March 2024. Instruments were reapplied after 15 days in 95 patients.
resultsThe scale demonstrated internal consistency, reliability, temporal stability, and convergent validity with the ESAS-r. The most prevalent symptoms were drowsiness (44%), difficulty walking (44%), fatigue/lack of energy (43%), and pain (36%). Less frequent symptoms included dyspnea (7%), diarrhea (14%), and vomiting (14%). Unbearable symptoms intensity was rare, including emotional symptoms (5%), difficulty sleeping (3%), and fatigue/lack of energy (3%). Symptom intensity varied, being severe for pain (24-25%) and drowsiness (21%); and moderate for difficulty walking (25%) and fatigue/lack of energy (22%).
conclusionThe Brazilian Portuguese version of the IPOS- renal is valid, reliable, and suitable for identifying biopsychosocial symptoms in stage 5 CKD patients receiving palliative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.